James Mason : Citation Profile


Are you James Mason?

4

H index

1

i10 index

55

Citations

RESEARCH PRODUCTION:

18

Articles

6

Papers

RESEARCH ACTIVITY:

   29 years (1993 - 2022). See details.
   Cites by year: 1
   Journals where James Mason has often published
   Relations with other researchers
   Recent citing documents: 3.    Total self citations: 7 (11.29 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pma2333
   Updated: 2024-12-03    RAS profile: 2023-04-09    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with James Mason.

Is cited by:

Gray, Alastair (2)

Schreiner, Mark (1)

Mortimer, Duncan (1)

Niessen, Louis (1)

Brazier, John (1)

Cites to:

Johannesson, Magnus (1)

Henningsen, Arne (1)

Sculpher, Mark (1)

Rice, Nigel (1)

Mason, Anne (1)

Jones, Andrew (1)

Goffe, William (1)

Husereau, Don (1)

Main data


Where James Mason has published?


Journals with more than one article published# docs
Health Policy4
Social Science & Medicine4
PharmacoEconomics4
Health Economics2
PLOS ONE2

Working Papers Series with more than one paper published# docs
Working Papers / Centre for Health Economics, University of York6

Recent works citing James Mason (2024 and 2023)


YearTitle of citing document
2023‘Let there be light’ or life in the dark? Vital geographies of mental healthcare. (2023). Philo, Chris ; Hogstrom, Ebba. In: Social Science & Medicine. RePEc:eee:socmed:v:333:y:2023:i:c:s027795362300494x.

Full description at Econpapers || Download paper

2023Inventive Activity for Climate Change Mitigation: An Insight into the Maritime Industry. (2023). Wagner, Natalia. In: Energies. RePEc:gam:jeners:v:16:y:2023:i:21:p:7403-:d:1272999.

Full description at Econpapers || Download paper

Works by James Mason:


YearTitleTypeCited
1995The DH register of cost-effectiveness studies: a review of study content and quality In: Working Papers.
[Full Text][Citation analysis]
paper1
1995Screening for diabetic retinopathy by optometrists: effectiveness and cost-effectiveness In: Working Papers.
[Full Text][Citation analysis]
paper0
1998NICEly does it: economic analysis within evidence-based clinical practice guidelines In: Working Papers.
[Full Text][Citation analysis]
paper0
1999Evaluating change in professional behaviour: issues in design and analysis In: Working Papers.
[Full Text][Citation analysis]
paper0
2002Topical preparations for the treatment of psoriasis in primary care: a systematic review In: Working Papers.
[Full Text][Citation analysis]
paper0
2002Optometrist prescribing of therapeutic agents: economic implications for the UK In: Working Papers.
[Full Text][Citation analysis]
paper0
1995Cost-effectiveness league tables: think of the fans In: Health Policy.
[Full Text][Citation analysis]
article6
1997Biotechnology: a special case for health technology assessment? In: Health Policy.
[Full Text][Citation analysis]
article2
1999A framework for incorporating cost-effectiveness in evidence-based clinical practice guidelines In: Health Policy.
[Full Text][Citation analysis]
article3
2002Optometrist prescribing of therapeutic agents: findings of the AESOP survey In: Health Policy.
[Full Text][Citation analysis]
article0
1993Cost-effectiveness league tables: More harm than good? In: Social Science & Medicine.
[Full Text][Citation analysis]
article19
2013Creating ‘therapeutic landscapes’ for mental health carers in inpatient settings: A dynamic perspective on permeability and inclusivity In: Social Science & Medicine.
[Full Text][Citation analysis]
article4
2013Spaces for smoking in a psychiatric hospital: Social capital, resistance to control, and significance for ‘therapeutic landscapes’ In: Social Science & Medicine.
[Full Text][Citation analysis]
article3
2013Compassionate containment? Balancing technical safety and therapy in the design of psychiatric wards In: Social Science & Medicine.
[Full Text][Citation analysis]
article5
2014Prophylactic Antibiotics to Prevent Cellulitis of the Leg: Economic Analysis of the PATCH I & II Trials In: PLOS ONE.
[Full Text][Citation analysis]
article0
2017Agreement between gastrointestinal panel testing and standard microbiology methods for detecting pathogens in suspected infectious gastroenteritis: Test evaluation and meta-analysis in the absence of In: PLOS ONE.
[Full Text][Citation analysis]
article0
2021Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial–Based Cost-Effectiveness Data In: Medical Decision Making.
[Full Text][Citation analysis]
article0
2000The Importance of Achieving Additional Drug Benefits at a Reasonable Cost In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2017Methodological Issues Surrounding the Use of Baseline Health-Related Quality of Life Data to Inform Trial-Based Economic Evaluations of Interventions Within Emergency and Critical Care Settings: A Sys In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2018Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2019Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2022The urgent case for stronger climate targets for international shipping In: Climate Policy.
[Full Text][Citation analysis]
article2
1995Reporting guidelines for economic studies In: Health Economics.
[Full Text][Citation analysis]
article9
1996Student corner In: Health Economics.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 3 2024. Contact: CitEc Team